Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory Multiple Myeloma will be presented in…
SAN FRANCISCO, July 25, 2023 (GLOBE NEWSWIRE) — Adaptive Research, an organization committed to democratizing…
Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory Multiple Myeloma will be presented in…
Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory Multiple Myeloma will be presented in…
Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory Multiple Myeloma will be presented in…
MIAMI, July 25, 2023 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the…
MIAMI, July 25, 2023 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the…
THB335 retains selectivity and potency of first-generation oral KIT inhibitor, THB001, with differentiated metabolic, distribution…
THB335 retains selectivity and potency of first-generation oral KIT inhibitor, THB001, with differentiated metabolic, distribution…
MALVERN, Pa., July 25, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
MALVERN, Pa., July 25, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
Mr. McEnany will Continue to Serve as Catalyst’s Non-Executive Chairman of the Board Following his…
Mr. McEnany will Continue to Serve as Catalyst’s Non-Executive Chairman of the Board Following his…
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic…
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic…
SAN DIEGO, July 25, 2023 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage…
SAN DIEGO, July 25, 2023 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage…
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel and…
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel and…
ROCKAWAY, N.J., July 25, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine…